Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatrics ; 121(4): e998-1002, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18316354

ABSTRACT

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome is a rare X-linked disorder that usually presents in early childhood with immune enteropathy, diabetes mellitus, and other autoimmune complications. The disease is caused by mutations in the forkhead box P3 gene, a transcription factor that is essential for the development and function of regulatory T cells. This population of cells plays an essential role in controlling immune responses and preventing autoimmunity. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome is often initially treated with immunosuppressive drugs, but only allogeneic hematopoietic stem cell transplantation has offered the possibility of cure. We recently performed an unrelated donor transplant in a child with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome by using a reduced-intensity conditioning regimen. This transplant provided a rare opportunity to gain valuable insight into the regeneration of the immune system after transplantation. Clinical recovery was associated with the emergence of regulatory T cell populations, the majority of which expressed memory phenotype markers and raised important questions about the origin and longevity of the FOXP3(+) regulatory T cell pool.


Subject(s)
Forkhead Transcription Factors/metabolism , Genetic Diseases, X-Linked/therapy , Peripheral Blood Stem Cell Transplantation/methods , Polyendocrinopathies, Autoimmune/diagnosis , Polyendocrinopathies, Autoimmune/therapy , T-Lymphocytes, Regulatory/immunology , Follow-Up Studies , Forkhead Transcription Factors/genetics , Gene Expression , Genetic Diseases, X-Linked/genetics , Genetic Diseases, X-Linked/immunology , Graft Survival , Humans , Infant , Male , Polyendocrinopathies, Autoimmune/genetics , Polymerase Chain Reaction , Protein-Losing Enteropathies/genetics , Protein-Losing Enteropathies/immunology , Protein-Losing Enteropathies/therapy , Risk Assessment , Syndrome , T-Lymphocytes, Regulatory/metabolism , Transplantation, Homologous , Treatment Outcome
2.
J Exp Med ; 204(9): 2213-24, 2007 Sep 03.
Article in English | MEDLINE | ID: mdl-17724125

ABSTRACT

Specific mutations in the human gene encoding the Wiskott-Aldrich syndrome protein (WASp) that compromise normal auto-inhibition of WASp result in unregulated activation of the actin-related protein 2/3 complex and increased actin polymerizing activity. These activating mutations are associated with an X-linked form of neutropenia with an intrinsic failure of myelopoiesis and an increase in the incidence of cytogenetic abnormalities. To study the underlying mechanisms, active mutant WASp(I294T) was expressed by gene transfer. This caused enhanced and delocalized actin polymerization throughout the cell, decreased proliferation, and increased apoptosis. Cells became binucleated, suggesting a failure of cytokinesis, and micronuclei were formed, indicative of genomic instability. Live cell imaging demonstrated a delay in mitosis from prometaphase to anaphase and confirmed that multinucleation was a result of aborted cytokinesis. During mitosis, filamentous actin was abnormally localized around the spindle and chromosomes throughout their alignment and separation, and it accumulated within the cleavage furrow around the spindle midzone. These findings reveal a novel mechanism for inhibition of myelopoiesis through defective mitosis and cytokinesis due to hyperactivation and mislocalization of actin polymerization.


Subject(s)
Actins/metabolism , Cytokinesis , Genetic Diseases, X-Linked/metabolism , Mitosis , Neutropenia/metabolism , Neutropenia/pathology , Wiskott-Aldrich Syndrome Protein/metabolism , Animals , Apoptosis/drug effects , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Proliferation/drug effects , Chromosome Aberrations , Chromosomes, Human , Cytokinesis/drug effects , DNA , Depsipeptides/pharmacology , Genetic Diseases, X-Linked/pathology , Green Fluorescent Proteins/metabolism , Humans , Mice , Mitosis/drug effects , Mutant Proteins/metabolism , Polyploidy , Recombinant Fusion Proteins/metabolism , Transgenes
3.
Mol Ther ; 15(2): 355-60, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17235314

ABSTRACT

Retroviral transfer of the Herpes Simplex thymidine kinase (HSVTK) suicide gene to donor T cells has been used as a safety strategy against graft-versus-host disease following allogeneic stem cell transplantation. The feasibility of this strategy in human studies has been demonstrated, but a number of limitations have become apparent. Preactivation of donor lymphocytes using mitogens or monoclonal antibodies is essential for retroviral transduction, but can compromise subsequent T-cell function in vivo. We report the application of lentiviral vectors for transduction of T cells in cytokine culture, without activation through the T-cell receptor. Using vectors encoding either enhanced green fluorescent protein or a truncated CD34/mutant HSVTK fusion selection/suicide construct, we investigated the properties of T cells after gene modification. We found that following cytokine stimulation, a fraction of T cells undergoes division, and transgene expression occurred predominantly in these cells. Antiviral and alloreactive responses were preserved in these populations, and in contrast to fully activated T cells, there was minimal perturbation of regulatory T-cell numbers. We conclude that the use of interleukin-7 for lentiviral transduction offers the greatest potential for gene transfer to T cells without loss of function, and is favored for the clinical production of suicide gene modified T cells.


Subject(s)
Genetic Vectors/genetics , Lentivirus/genetics , T-Lymphocytes/metabolism , Transfection/methods , Cytokines/pharmacology , Flow Cytometry , Genes, Transgenic, Suicide/genetics , Genetic Therapy/methods , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Interleukin-7/genetics , Interleukin-7/metabolism , Simplexvirus/genetics , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , Thymidine Kinase/genetics , Thymidine Kinase/metabolism
4.
Blood ; 108(7): 2182-9, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16804117

ABSTRACT

Severe congenital neutropenia (SCN) is characterized by neutropenia, recurrent bacterial infections, and maturation arrest in the bone marrow. Although many cases have mutations in the ELA2 gene encoding neutrophil elastase, a significant proportion remain undefined at a molecular level. A mutation (Leu270Pro) in the gene encoding the Wiskott-Aldrich syndrome protein (WASp) resulting in an X-linked SCN kindred has been reported. We therefore screened the WAS gene in 14 young SCN males with wild-type ELA2 and identified 2 with novel mutations, one who presented with myelodysplasia (Ile294Thr) and the other with classic SCN (Ser270Pro). Both patients had defects of immunologic function including a generalized reduction of lymphoid and natural killer cell numbers, reduced lymphocyte proliferation, and abrogated phagocyte activity. In vitro culture of bone marrow progenitors demonstrated a profound reduction in neutrophil production and increased levels of apoptosis, consistent with an intrinsic disturbance of normal myeloid differentiation as the cause of the neutropenia. Both mutations resulted in increased WASp activity and produced marked abnormalities of cytoskeletal structure and dynamics. Furthermore, these results also suggest a novel cause of myelodysplasia and that male children with myelodysplasia and disturbance of immunologic function should be screened for such mutations.


Subject(s)
Mutation , Neutropenia/congenital , Neutropenia/genetics , Wiskott-Aldrich Syndrome Protein/genetics , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , COS Cells , Cell Proliferation , Child , Child, Preschool , Chlorocebus aethiops , Humans , Leukocyte Elastase/metabolism , Lymphocytes/cytology , Male , Neutropenia/metabolism , U937 Cells , Wiskott-Aldrich Syndrome Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...